Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | SCN1A | P35498 | 1/20 | 0.43 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.43 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5602707 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL9906968 | 0.84 | ALDH1A1 (0.48) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL5603051 | 0.83 | ALDH1A1 (0.39) | ALDH1A1TSHRL3MBTL1KDM4EHSD17B10 | |
| SCHEMBL5604151 | 0.83 | ALDH1A1 (0.39) | ALDH1A1TSHRL3MBTL1KDM4EHSD17B10 | |
| SCHEMBL9940061 | 0.80 | LMNA (0.50) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL25996839 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL15876039 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL6062118 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL6061391 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHRSCN1ASCN2ASCN3A | |
| SCHEMBL6062530 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHRSCN1ASCN2ASCN3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1818361-B1 | Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) | OCCIDENTAL CHEM CO (US) | 2013-07-24 | — | — | EP | disclosed |
| EP-1818361-A2 | Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) | OCCIDENTAL CHEMICAL CORPORATION (US) | 2007-08-15 | — | — | EP | disclosed |
| EP-1313802-B1 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEM CO (US) | 2007-06-20 | — | — | EP | disclosed |
| US-6451904-B1 | DISCOLORATION INHIBITION OF POLYVINYL CHLORIDE WHEN EXPOSED TO IONIZING RADIATION | OCCIDENTAL CHEMICAL CORPORATION | 2002-09-17 | — | — | US | disclosed |
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | OCCIDENTAL CHEMICAL CORPORATION | 2002-05-09 | — | — | US | disclosed |
| US-6348517-B1 | HALOGEN CONTAINING POLYMERS WITH STABILIZERS FOR STERILE ARTICLES | OXY SERVICES, INC. | 2002-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | SFN, XRCC6, SPOUT1 | ALDH1A1 3954/4885TSHR 1248/4885SCN1A 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.